Click. Watch. Learn.

During this webcast, cardiology specialist, Dr. Rebecca L. Stepien will cover the identification and staging of heart disease in cats, including the diagnosis and treatment of preclinical heart disease and congestive heart failure.

In conjunction with the most current recommendations of the ACVIM consensus guidelines for the classification, diagnosis, and management of cardiomyopathy in cats, she will also discuss the use of the following assessments:

• physical assessment;
• non-echocardiographic assessment including NT-proBNP evaluation; and,
• simple echocardiographic assessment.

During this webcast, cardiology specialist and professor, Dr. Sonya G. Gordon will provide a quick overview of the ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. She will also delve into some important questions regarding the following topics:

• diagnosing the various ACVIM stages of canine heart disease and failure with a focus on Stage B2;
• the current recommended treatment for the various ACVIM stages of mitral valve disease;
• what are the “must-use” treatments and when to administer them if owners are financially restricted;
• the minimum database and findings necessary before veterinarians can confidently recommend treatment; and,
• recommendations for case monitoring throughout the various stages.

In Canada, Echinococcus multilocularis had never been reported in a dog before 2009. There have since been multiple cases of alveolar echinococcosis in dogs throughout the country.

In this presentation, parasitology specialist Dr. Andrew S. Peregrine will provide a summary of these canines cases, as well as of human cases reported over the same period. He will also discuss strategies to reduce the risk of infection in dogs and people.

In this presentation, parasitology specialist Dr. Andrew Peregrine will review the most current information available on the risk of ticks and tick-borne diseases in companion animals across Canada, as well as the recommendations from the 2018 ACVIM consensus statement on Lyme disease in dogs and cats, including:

• the utility of routine screening;
• the management of seropositive animals;
• prevention strategies.

Watch this video presentation to learn how to:

• Recognize the impact of appropriate OA management in veterinary patients
• Implement practical OA treatment strategies
• Understand the current OA therapies available to veterinarians

Watch the video, read the complementary text and complete the CE quiz to obtain a certificate for a one-hour CE credit.

This webcast is part of the VaxTalk Thursdays Live Webcast Series

Take advantage of this rare opportunity to “talk vaccination” with this internationally-renowned veterinary specialist, lead editor of the AAHA Canine Vaccine Guidelines and co-author of the AAFP Feline Vaccine Guidelines!

This presentation provides new insights on maternally-derived antibody interference, genetic factors surrounding patient response to vaccination, the ‘overdue’ patient, vaccine storage and handling issues leading to ineffective immunization… and the role of antibody testing to assess individual patient response to vaccination.

This webcast is part of the VaxTalk Thursdays Live Webcast Series

Take advantage of this rare opportunity to “talk vaccination” with this internationally-renowned veterinary specialist, lead editor of the AAHA Canine Vaccine Guidelines and co-author of the AAFP Feline Vaccine Guidelines!

This presentation on canine Lyme disease provides insight into critical risk factors unique to Canada, diagnostic considerations (and controversy), the role of co-infection in patient outcomes and management, as well as key issues surrounding prevention… including the role of Lyme disease vaccine in practice.

This webcast is part of the VaxTalk Thursdays Live Webcast Series

Take advantage of this rare opportunity to “talk vaccination” with this internationally-renowned veterinary specialist, lead editor of the AAHA Canine Vaccine Guidelines and co-author of the AAFP Feline Vaccine Guidelines!

This presentation offers a succinct review of critical factors surrounding diagnosis and prevention of leptospirosis, zoonotic potential of leptospirosis in dogs, and controversial topics surrounding Leptospira vaccination: Core or non-core? Booster intervals? ‘Overdue’ for a booster?

This webcast is part of the VaxTalk Thursdays Live Webcast Series

Take advantage of this rare opportunity to “talk vaccination” with this internationally-renowned veterinary specialist, lead editor of the AAHA Canine Vaccine Guidelines and co-author of the AAFP Feline Vaccine Guidelines!

This presentation offers a graphic review of the major types of reactions (acute and delayed) currently recognized in veterinary medicine, vaccine response vs. reaction, strategies for minimizing patient risk, and patient management options.

Clients have expressed a need for consistent recommendations from their veterinary staff regarding parasite prevention and treatment. During this presentation, Dr. Danny Joffe will review parasite protocols, and how they allow for proper in-clinic compliance. He also examines the clinical signs of the most common parasites, their diagnosis, and treatment, and discusses team education and protocol implementation.

Discover the results of the VALVE study on dual vs. triple therapy – it could change the way you treat congestive heart failure (CHF) due to myxomatous mitral valve disease (MMVD).

A review of the diagnosis and management of canine acquired heart disease. The talk emphasizes diagnosing and managing the disease in the general practice setting, and helps clinicians to develop a clinic protocol to manage patients with asymptomatic heart disease as well as those with congestive heart failure.

Dr. Gordon, an internationally-known veterinary cardiologist, shares the latest evidence concerning treatment of the two most common canine heart conditions. Watch and learn practical tips on how general veterinary practitioners can screen, monitor and treat dogs with pre-clinical and clinical dilated cardiomyopathy, and myxomatous mitral valve disease.

Dr. Gordon, an internationally-known veterinary cardiologist, shares the latest evidence concerning treatment of the two most common canine heart conditions. Watch and learn practical tips on how general veterinary practitioners can screen, monitor and treat dogs with pre-clinical and clinical dilated cardiomyopathy, and myxomatous mitral valve disease.

Despite a growing recognition of the importance of pain assessment and management in veterinary medicine, persistent myths and misconceptions often undermine effective and safe pain management. In this question and answer video with Dr. Mathews, selective but common misconceptions and myths are addressed, on an evidence-based medicine approach, with the goal of supporting veterinary implementation of optimal pain management in dogs and cats.

Additional information: Hunt J An Analysis Of The Relative Frequencies Of Reported Adverse Event

In this webinar, Dr. Caney provides an overview of managing the senior and geriatric cat through the implementation of the “well cat protocol” with the goal of early illness identification and intervention, and a focus on maximizing quality and quantity of life. She defines key components of the "well cat protocol" based on age and the likelihood of identifying an existing disease that would benefit from intervention, and includes tips on protocol implementation that encompass the entire veterinary healthcare team.

Follow Dr. Joffe as he reviews the diagnosis and management of canine acquired heart disease. He focuses on diagnosing and managing the disease in the general practice setting, and helps clinicians develop a clinic protocol to manage patients with asymptomatic heart disease, as well as those with clinical congestive heart failure.